Insider transactions

James T McCubbin

CIK 1257635 · CFO, VP, Secretary · last filed 2017-10-25

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$1.2K
Companies
2
Total Filings
22
Lifetime Open-Market Net
-$597.5K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

WYY price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WYY CFO, VP, Secretary 164 $7.20 $1.2K -$598.8K 13 2017-10-25
ProPhase Labs, Inc. (PRPH) Delisted Director 3,183 $0.11 $350 $1.3K 9 2015-01-05

Recent Filings · Page 2 of 3

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-10-11 ProPhase Labs, Inc. (PRPH) Delisted Grant (A) +5,640 $0 EDGAR
2011-07-14 ProPhase Labs, Inc. (PRPH) Delisted Grant (A) +5,460 $0 EDGAR
2011-04-21 ProPhase Labs, Inc. (PRPH) Delisted Grant (A) +3,620 $0 EDGAR
2011-01-31 ProPhase Labs, Inc. (PRPH) Delisted Grant (A) +3,590 $0 EDGAR
2010-11-19 WYY Mixed +325,000 -$13.5K EDGAR
2010-11-18 ProPhase Labs, Inc. (PRPH) Delisted Grant (A) +3,533 $0 EDGAR
2010-10-08 WYY Mixed +75,000 -$276.2K EDGAR
2010-07-12 ProPhase Labs, Inc. (PRPH) Delisted Grant (A) +3,260 $0 EDGAR
2010-02-22 WYY Sell (S) −200,000 -$150.0K EDGAR
2009-07-24 WYY Mixed +793,103 -$0 EDGAR
Showing 11–20 of 22
Page 2 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.